Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/20/2010CN101862382A Pearl health care product for improving sleeping
10/20/2010CN101862380A Medicinal composition
10/20/2010CN101862378A Medicinal composition
10/20/2010CN101862374A Lotus plumule and new application of extractive thereof
10/20/2010CN101862365A Anti-tumour terpene compounds
10/20/2010CN101862348A Compound containing turtle serum and application thereof
10/20/2010CN101862346A Hypoglycemic application of gingseng acidic polysaccharide
10/20/2010CN101862345A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
10/20/2010CN101862344A Mouthwash preparation containing nysfungin
10/20/2010CN101862343A Application of luteolin 3'-glucoronide to preparing anti-hepatitis B virus medicine
10/20/2010CN101862342A External medicament for treating dermatophytosis
10/20/2010CN101862341A Application of Spinosad for wound healing
10/20/2010CN101862340A Application of lactose derivatives Gu-4 used as medicine for treating endotoxin shock
10/20/2010CN101862339A Use of cryptotanshinone as radiation sensitizing medicament in oncotherapy
10/20/2010CN101862338A Progesterone composite preparations for controlling rutting of sheep
10/20/2010CN101862337A Drug composite containing limaprost and preparation method thereof
10/20/2010CN101862336A Irbesartan-hydrochlorothiazide drug combination liposome solid preparation
10/20/2010CN101862335A Medicine compound containing mycophenolate mofetil
10/20/2010CN101862334A Application of evodiamine in preparation of preparation for resisting white spot syndromevirus
10/20/2010CN101862333A Stable sodium levofolinate oral preparation and preparation method thereof
10/20/2010CN101862332A Composition for preventing human body injuries by excessive consumption of alcohol and preparation method and application thereof
10/20/2010CN101862331A New use of methyl liensinine
10/20/2010CN101862330A Bicyclic amide derivatives for the treatmet of respiratory disorders
10/20/2010CN101862329A Amlodipine besylate and atorvastatin calcium medicine compound liposome solid preparation
10/20/2010CN101862328A Valsartan amlodipine capsule medicine compound and preparation method thereof
10/20/2010CN101862327A Application of monascus colors and derivatives in preparing drugs for treating cardiovascular and cerebrovascular diseases
10/20/2010CN101862326A Medicine compound containing febuxostat
10/20/2010CN101862325A Medicine compound containing candesartan cilexetil
10/20/2010CN101862324A Application of monascus color components and derivatives thereof in fighting cancers
10/20/2010CN101862323A Application of 1,2-O-stearyl glyceraldehyde in preparing antibacterial agents
10/20/2010CN101862322A Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
10/20/2010CN101862321A Pharmaceutical composition with functions of hemangiectasis and beta 1 receptor retardation
10/20/2010CN101862320A Solid preparation of ranitidine hydrochloride/bismuth potassium citrate medicinal composition
10/20/2010CN101862319A Docetaxel combination for injection and preparation method thereof
10/20/2010CN101862318A Combined medicament-combined linolenic acid capable of preventing and fundamentally treating thromboembolic diseases
10/20/2010CN101862317A Pregabalin derivatives for the treatment of fibromyalgia and other disorders
10/20/2010CN101862316A Application of vanillic acid in prevention and treatment of radiation injury
10/20/2010CN101862315A Application of disubstituted phenyl biguanide to inducing malignant tumor cell for anoikis
10/20/2010CN101862314A Application of quinine compound in preparing anti-tubercle bacillus drugs
10/20/2010CN101862313A Application of anthracycline compound in preparing anti-breast cancer medicines
10/20/2010CN101862312A New application of 6-gingerol
10/20/2010CN101862311A Penetration promoting and eyesight improving eye drop
10/20/2010CN101862310A Transdermal system for varenicline
10/20/2010CN101862309A Glipizide sustained-release capsule and preparation method thereof
10/20/2010CN101862307A Bisulfate Cefdinir sodium capsule and preparation method thereof
10/20/2010CN101862306A New type slightly soluble oral medicine self-emulsification preparation and preparation method thereof
10/20/2010CN101862305A Ambroxol hydrochloride sustained-release pellet and preparation method
10/20/2010CN101862304A Uncaria sustained-release tablet and preparation method thereof
10/20/2010CN101862303A Roxithromycin sustained release tablets and preparation method thereof
10/20/2010CN101862302A Amlodipine besylate liposome tablet
10/20/2010CN101862301A Tartraric rosiglitazone sustained release tablet and preparation method thereof
10/20/2010CN101862300A Lovastatin dispersible tablet and preparation method thereof
10/20/2010CN101862299A Preparation method of aspoxicillin freeze-dried powder injection
10/20/2010CN101862298A Benproperine phosphate granular formulation
10/20/2010CN101862297A Water-insoluble medicine sustained-release pellet, sustained-release orally disintegrating tablet thereof and preparation method thereof
10/20/2010CN101862296A Cefmetazole sodium composition powder injection for injection
10/20/2010CN101862295A Aggregate having enhanced deformability and including at least three amphipatic substances
10/20/2010CN101862294A Ivermectin suspending agent, preparation method and application thereof
10/20/2010CN101862293A Doxycycline hydrochloride oil turbid liquor, preparation method and application thereof
10/20/2010CN101862292A Ibuprofen suspension
10/20/2010CN101862233A Drug-delivery endovascular stent and method for treating restenosis
10/20/2010CN101361751B Moisture absorption self-adhesion barrier film capable of preventing postoperative adhesions and preparation method thereof
10/20/2010CN101357116B Transdermal and transmucosal local narcotic analgesic and preparation method of gel formulation thereof
10/20/2010CN101278976B Quality control method of Shangke bone-knitting medicine
10/20/2010CN101239092B Kudzuvine flower isoflavonoid extraction, its extracting method, medicinal composition and its use in pharmaceutical
10/20/2010CN101234148B Pure Chinese medicine powder for treating bedsore, scald and burn
10/20/2010CN101225106B Short peptide suppressing growth of cancer cell and uses thereof
10/20/2010CN101167707B New use of protocatechuic aldehyde
10/20/2010CN101165047B Glycolipid derivative and its manufacturing method, and its synthesizing intermediate and its manufacturing method
10/20/2010CN101164530B Aqueous solution containing stable sodium pyrouvate and preparing method and use thereof
10/20/2010CN101134040B Application of forsythiaside in the preparation of medicament for treating or preventing acute and chronic liver damnification and liver fibrosis
10/20/2010CA2663327A1 Methods and compositions for promoting the neurological development of an infant
10/19/2010US7816560 N-nonyl-1,5,6-trideoxy-1,5-imino-D-galactitol; N-(7-oxa-nonyl)-1,5,6-trideoxy-1,5-imino-D-galactito; viricide; for treating hepatitis
10/19/2010US7816557 Glucagon receptor antagonists, preparation and therapeutic uses
10/19/2010US7816546 Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
10/19/2010US7816542 Compounds and compositions as TPO mimetics
10/19/2010US7816540 Carboxyl- or hydroxyl-substituted benzimidazole derivatives
10/19/2010US7816539 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/19/2010US7816538 2-Methylamino-N-{2-(6-{1-methyl-2-(2-methylamino-propionylamino)-3-oxo-3-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-yl]-propoxy}-hexa-2,4-diynyloxy)-1-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-carbonyl]-propyl}-propionamide; mimetics of second mitochondria-derived activator of caspases
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816532 Biphenyl compounds useful as muscarinic receptor antagonists
10/19/2010US7816529 Sodium and calcium channel antagonists; higher potency; fewer side effects to central nervous system
10/19/2010US7816528 Preparation of aminopyrimidine compounds
10/19/2010US7816522 Triazolone derivatives
10/19/2010US7816521 1,2,4-benzotriazine-1,4-dioxides
10/19/2010US7816518 Porphyrin derivatives and their use in photon activation therapy
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816511 Screening drugs; prevent gene expression; monitoring cardiovascular disorders
10/19/2010US7816409 comprising a fluoroether anesthetic compound selected from sevoflurane, desflurane, isoflurane, enflurane and methoxyflurane, and at least one stabilizer agent selected from propylene glycol, polyethylene glycol, hexylene glycol, 1,3-butylene glycol and a saturated cyclic alcohol preferably menthol
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/19/2010US7816407 For therapy and prophylaxis of central nervous system dependent conditions
10/19/2010US7816406 such as 2-Methylsulfanyl-5-oxo-5H-7-thia-1,3,11b-triaza-benzo[c]fluorene-6-carboxylic acid ethyl ester; antiproliferative agents; apoptosis inducers
10/19/2010US7816405 Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
10/19/2010US7816404 combining citrate ion source, pyrophosphate ion source, and ferric ion source in water to form a solution, adding an organic solvent to precipitate solid ferric pyrophosphate citrate chelate composition, and isolating citrate chelate having 2% or less phosphate by weight; treating iron deficiency
10/19/2010US7816403 Administering a thiuram disulfide and a heavy metal ion; activated transcription factor/adenosine cyclic phosphate response element binding protein (atf/creb)
10/19/2010US7816402 Compositions and methods for the treatment of skin
10/19/2010US7816401 Process for total synthesis of pladienolide B and pladienolide D
10/19/2010US7816400 Composition comprising natural flavone acacetin, or a pharmaceutically active derivative, analog, salt, glycoside, ester, amide or stereoisomer thereof, effective to inhibit potassium channel function in a patient in need thereof, formulated with a pharmaceutically acceptable vehicle
10/19/2010US7816399 Synergistic combination of prostaglandin and nitric oxide donor compounds; ocular hypertension and glaucoma
10/19/2010US7816398 Fatty alcohol drug conjugates
1 ... 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 ... 7860